Steimer T, Hutchison J B
Brain Res. 1981 Mar 23;209(1):189-204. doi: 10.1016/0006-8993(81)91180-x.
In vitro studies of androgen metabolism in the dove brain show that testosterone is rapidly converted to 5 beta-reduced metabolites (5 beta-dihydrotestosterone and the two corresponding 3 alpha/3 beta diols). The preoptic region and the anterior ventromedial and posterior hypothalamus which are target areas for androgen action on behaviour and the neuroendocrine system show significantly less 5 beta-reduction than adjacent parolfactory, septal and striatal areas not directly involved in androgen action. In contrast to 5 alpha-reduction and aromatization, which lead to the formation of active metabolites in the dove brain, 5 beta-reduction is likely to be part of a testosterone (T) inactivation mechanism because: (a) intrahypothalamic implants of 5 beta-dihydrotestosterone were ineffective for male behaviour in the dove; (b) 5 beta-reduced metabolites of T were not detected in hypothalamic cell nuclei following intramuscular injection of tritiated testosterone, and were rapidly eliminated from brain cells; (c) the 4 beta-diols were also found to be a major product of T catabolism in the liver, a site of androgen inactivation. Long-term androgen deficit induced by castration increased 5 beta DHT formation in the preoptic area, but not in an adjacent parolfactory area. The increase was reversed by exogenous testosterone and oestradiol-17 beta indicating that the 5 beta-reduction pathway in an androgen-sensitive brain area is influenced by hormonal conditions. It is suggested that 5 beta-reduction is a testosterone inactivation pathway involved in the regulation of brain sensitivity to androgens.